SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
ShockWave Medical, Inc.
(Exact name of registrant as specified in its charter)
(State of incorporation
5403 Betsy Ross Drive
Santa Clara, California
|(Address of principal executive offices)||(Zip Code)|
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange on which
par value $0.001 per share
The Nasdaq Stock Market LLC
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. þ
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box.
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box.
Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333- 229590
Securities to be registered pursuant to Section 12(g) of the Act: None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
|Item 1.||Description of Registrant’s Securities to be Registered.|
A description of the registrant’s common stock, par value $0.001 per share, registered hereby is set forth under the caption “Description of Capital Stock” in the registrant’s registration statement on Form S-1 (File No. 333-229590) filed with the Securities and Exchange Commission on February 8, 2019, as thereafter amended (the “Registration Statement”), which is incorporated herein by reference. Any prospectus that constitutes part of the Registration Statement and is filed by the registrant pursuant to Rule 424(b) under the Securities Act of 1933 shall be deemed incorporated herein by reference.
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
|Dated: March 5, 2019||
ShockWave Medical, Inc.
|By:||/s/ Dan Puckett|
|Title:||Chief Financial Officer and Secretary|